ABIVAX (EPA:ABVX) | WebDisclosure

PRESS RELEASE

published on 08/13/2025 at 18:00, 7 months 8 days ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote
ABIVAX communique le nombre total de droits de vote et d'actions conformément à la réglementation en vigueur. Abivax se focalise sur le développement de traitements thérapeutiques pour les maladies inflammatoires chroniques

Droits De Vote Actions Abivax Traitements Thérapeutiques Maladies Inflammatoires
PRESS RELEASE

published on 08/13/2025 at 18:00, 7 months 8 days ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote
ABIVAX communique le nombre d'actions composant son capital social et le nombre total de droits de vote conformément aux dispositions réglementaires

Droits De Vote Capital Social Abivax Finance Réglementaire
BRIEF

published on 07/28/2025 at 22:20, 7 months 24 days ago

Abivax conclut une offre publique de 747,5 millions de dollars

Biotechnologie Abivax Nasdaq Rectocolite Hémorragique Offre Publique
BRIEF

published on 07/28/2025 at 22:20, 7 months 24 days ago

Abivax Completes $747.5 Million Public Offering

Biotechnology Abivax Ulcerative Colitis Nasdaq Public Offer
PRESS RELEASE

published on 07/28/2025 at 22:15, 7 months 24 days ago

Abivax Announces Closing of $747.5 Million Public Offering
Abivax announces closing of $747.5 million public offering, enabling financing into Q4 2027 and reaching planned milestones for Ulcerative Colitis. ADSs listed on Euronext Paris and Nasdaq Global Market

Abivax Ulcerative Colitis Nasdaq Finance Public Offering
PRESS RELEASE

published on 07/28/2025 at 22:15, 7 months 24 days ago

Abivax annonce la réalisation de son offre au public de 747,5 millions de dollars
Abivax réalise une offre publique de 747,5 millions de dollars pour financer ses activités jusqu'en 2027. Cotée en bourse à Paris et Nasdaq, elle se concentre sur les maladies inflammatoires

Financement Abivax Bourse Offre Publique Maladies Inflammatoires
BRIEF

published on 07/25/2025 at 08:05, 7 months 28 days ago

Abivax Raises $747.5M Through ADS Offering

Biotechnology Abivax Nasdaq Capital Increase ADS Offering
BRIEF

published on 07/25/2025 at 08:05, 7 months 28 days ago

Abivax lève 747,5 millions de dollars grâce à une offre publique d'achat (ADS)

Biotechnologie Abivax Nasdaq Augmentation De Capital Offre ADS
PRESS RELEASE

published on 07/25/2025 at 08:00, 7 months 28 days ago

Abivax annonce l’exercice intégral de l’option de souscription d’ADS supplémentaires des teneurs de livre associés, portant le produit brut de l'Offre à 747,5 M$ (637,5 M€)
Abivax annonce exercice intégral option souscription ADS supplémentaires. Produit brut Offre à 747,5 M$. Société biotechnologie spécialisée en immunothérapie. Prix offre 64,00$ par ADS. Actions admises Nasdaq et Euronext. Document relatif déposé auprès de la SEC

Biotechnologie Abivax SEC Immunothérapie Prix Offre
PRESS RELEASE

published on 07/25/2025 at 08:00, 7 months 28 days ago

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)
Abivax announces full exercise of underwriters’ option to purchase additional ADSs, bringing gross proceeds of offering to $747.5M (€637.5M). Company to apply net proceeds to identified use of funds

Abivax Underwriters ADSs Offering Proceeds

Published on 03/20/2026 at 23:00, 1 day 13 hours ago

Cypher Announces Private Placement
Published on 03/20/2026 at 21:30, 1 day 14 hours ago

Sky Gold Sets Options
Published on 03/20/2026 at 21:15, 1 day 15 hours ago

Earthwise Minerals Announces Private Placement
Published on 03/20/2026 at 13:30, 1 day 22 hours ago

Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 1 day 23 hours ago

CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals

View all ACCESSWIRE

Published on 03/20/2026 at 22:45, 1 day 13 hours ago

Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 1 day 15 hours ago

Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 1 day 15 hours ago

Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 21:00, 1 day 15 hours ago

BRP Unveils the Winners of its 6th International Design Challenge
Published on 03/20/2026 at 20:05, 1 day 16 hours ago

INVESTOR ALERT: Goeasy Ltd. Shareholder Class Action

View all EQS

Published on 03/20/2026 at 19:00, 1 day 17 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 1 day 17 hours ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 1 day 18 hours ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 1 day 18 hours ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
Published on 03/20/2026 at 17:45, 1 day 18 hours ago

Cie du Bois Sauvage : Jaarverslag 2025

View all LES ECHOS COMFI WIRE

News